Tirzepatide therapy — Grace Longevity
GLP-1 / GIP Dual-Action Therapy

Tirzepatide

Compounded tirzepatide — the same active ingredient as Mounjaro® and Zepbound® — delivering superior metabolic results through a novel dual-receptor mechanism of action.

Starting at

$349 / month

Includes physician consultation, prescription, and pharmacy dispensing

Start My Assessment

You must be evaluated by a physician to receive a prescription. Consult fee applies whether or not you are a candidate.


The Science

Dual-Receptor Action

Tirzepatide is the first and only medication of its class — a dual GIP and GLP-1 receptor agonist. While semaglutide targets one receptor, tirzepatide activates two, resulting in synergistic effects on appetite suppression and metabolic function.

GIP (glucose-dependent insulinotropic polypeptide) works alongside GLP-1 to amplify insulin secretion, reduce glucagon levels, and slow gastric emptying — producing more robust weight loss outcomes in clinical trials.

The SURMOUNT-1 trial demonstrated an average weight reduction of up to 22.5% body weight at the highest dose — the most significant weight loss ever recorded in a pharmaceutical clinical trial.

Dual receptor mechanism visualization

How They Compare

Semaglutide vs. Tirzepatide

Semaglutide Tirzepatide
Mechanism GLP-1 receptor agonist Dual GLP-1 + GIP agonist
Avg. Weight Loss ~15% Up to 22.5%
Dosing Frequency Weekly injection Weekly injection
Starting Price $299/mo $349/mo
Best For Moderate weight loss goals Maximum metabolic results

Your physician will recommend the most appropriate therapy based on your health profile.


What to Expect

Your First 90 Days

Wk 1–4

Starting Dose

2.5mg weekly. A low starting dose ensures your body acclimates to the medication.

Wk 5–8

First Escalation

Dose increases to 5mg. Appetite suppression becomes noticeably stronger for most patients.

Wk 9+

Therapeutic Range

Your physician guides you to your optimal maintenance dose (5–15mg). Most patients see 1–2 lbs of loss per week during this phase.


The Full Picture

What Six Months Looks Like

Tirzepatide's results build over time — and the patients who reach month 3 and beyond are the ones who experience its full potential.

Month 1

Calibration Phase

The lowest dose allows your body to adjust to the dual GLP-1/GIP mechanism. Appetite signals begin to shift. Most patients notice reduced hunger and slower gastric emptying within the first 2 weeks. Average weight loss: 3–5 lbs.

Starting dose — 2.5mg weekly
Month 2

Dual Action Activates

Dose moves to 5mg and the combined GLP-1/GIP effect becomes pronounced. Cravings diminish significantly. Energy stabilizes. Most patients report this as the month the medication "clicked." Average weight loss: 8–14 lbs cumulative.

First escalation — 5mg weekly
Month 3

The Inflection Point

Tirzepatide's superiority over other GLP-1 medications becomes most visible here. Weight loss accelerates, metabolic improvements compound, and patients report the most significant lifestyle shift. Average weight loss: 15–22 lbs cumulative.

Most patients see this at month 3
Month 4–5

Compounding Results

At higher therapeutic doses, weight loss continues at a pace that exceeds any other pharmaceutical option available. Blood sugar, blood pressure, and cardiovascular markers improve measurably. Average weight loss: 22–35 lbs cumulative.

Therapeutic range — 7.5–10mg weekly
Month 6

Record-Breaking Results

The SURMOUNT-1 trial — the largest weight loss result ever recorded in a pharmaceutical clinical trial — showed up to 22.5% total body weight reduction. For a 200 lb patient, that is 45 lbs. Month 6 is where tirzepatide separates itself from everything else.

SURMOUNT-1 clinical benchmark

The Grace Care Plan keeps your prescription active, your physician monitoring your progress, and your medication arriving automatically — so you never lose momentum.

Start My Journey

Transparent Pricing

What You Pay. Nothing Hidden.

Private pay means no insurance games, no surprise bills. Your cost is determined by your physician-prescribed dose.

Starting Dose

$349/mo

2.5mg weekly

  • Physician review included
  • Prescription + dispensing
  • Discreet cold-chain shipping

Therapeutic Dose

$399–499/mo

5mg–15mg weekly (per physician guidance)

  • Everything in starting tier
  • Higher dose vial dispensed
  • Physician-guided dose escalation

Grace Care Plan

Included

Optional — opt out anytime with 30-day notice

  • Monthly physician check-ins
  • Automatic medication refill
  • Ongoing dose adjustments

Consultation fee applies whether or not you are determined to be a candidate. Pricing is subject to physician-prescribed dose. No insurance accepted.

Check My Eligibility

Takes under 10 minutes. No commitment required.


Clinical Evidence

What the Data Shows

From the SURMOUNT-1 Phase 3 trial — 2,500+ participants, 72 weeks. The most powerful GLP-1 / GIP dual therapy studied to date.

20.9%

Average Weight Loss

15mg dose group, 72 weeks

91%

Lost ≥5% Body Weight

vs. 35% on placebo

57%

Lost ≥20% Body Weight

15mg dose, approaching surgical outcomes

2x

Receptor Targets

GLP-1 + GIP — dual-action mechanism

Results are from peer-reviewed clinical trials and represent population averages. Individual results vary. This is not a guarantee of outcome. SURMOUNT-1 trial reference →


Common Questions

Tirzepatide FAQ

How much does tirzepatide cost at Grace Longevity?

Tirzepatide therapy starts at $349 per month. This includes physician consultation, prescription issuance, and pharmacy dispensing. A consultation fee applies whether or not you are ultimately determined to be a candidate.

Is tirzepatide better than semaglutide?

In clinical trials, tirzepatide's dual mechanism produced superior average weight loss — up to 22.5% body weight reduction vs. approximately 15% for semaglutide. The best option for you depends on your individual health profile, history, and goals, and is determined by your physician.

Is this the same as Mounjaro or Zepbound?

Grace Longevity dispenses compounded tirzepatide — not the brand-name drugs Mounjaro® or Zepbound®. Compounded tirzepatide contains the same active ingredient and is prescribed by licensed independent physicians, but is prepared and dispensed by a licensed compounding pharmacy rather than the brand manufacturer.

How do I qualify for tirzepatide?

General eligibility includes a BMI of 30 or greater, or a BMI of 27 or greater with a weight-related condition such as hypertension or type 2 diabetes. Final eligibility is always determined by an independent licensed physician after reviewing your health profile.

How quickly will I receive my medication after approval?

After physician approval, your prescription is sent directly to a licensed pharmacy and shipped to your door. Most patients receive their medication within 3–5 business days of approval.

Ready?

Begin Your Tirzepatide Assessment

Complete a brief intake and our physician network will determine if tirzepatide is appropriate for your goals and health history.

Begin My Assessment

Consultation fee applies regardless of candidacy outcome.